Nasal Decongestants [nosní dekongestiva]
topical
74
- Terms
-
dekongestiva
nosní dekongestanty
vasokonstrikční látky nosní
vasokonstriktiva nosní
vazokonstrikční nosní látky
vazokonstriktiva nosní
-
Decongestant
Decongestants
Nasal Decongestant
Vasoconstrictor Agents, Nasal
Vasoconstrictors, Nasal
Persistent link
https://www.medvik.cz/link/D014663
Definition
Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993)
- Annotation
- Nasal Decongestants - do not use entry term VASOCONSTRICTOR AGENTS, NASAL for the nasal administration of systemic vasoconstrictor agents; use instead the specific vasoconstrictor agent / admin + ADMINISTRATION, INTRANASAL
- DUI
- D014663 MeSH Browser
- CUI
- M0022552
- Previous indexing
- Sympathomimetics (1966)
- History note
- 96; was VASOCONSTRICTOR AGENTS, NASAL 1967-95; NASAL DECONGESTANTS was see VASOCONSTRICTOR AGENTS, NASAL 1967-95
- Public note
- 96; was VASOCONSTRICTOR AGENTS, NASAL 1967-95; NASAL DECONGESTANTS was see VASOCONSTRICTOR AGENTS, NASAL 1967-95
Allowable subheadings
- AD
- administration & dosage 23
- AE
- adverse effects 16
- AG
- agonists
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry 1
- CL
- classification 7
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 1
- PD
- pharmacology 17
- PO
- poisoning 1
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 45
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records